← back to search

F. Xiao‐Feng Qin

Chongqing University · CN
Area of research
Immunology · Oncology
Research interest
Research interests include Immune Cell Function and Interaction, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, and interferon and immune responses.
h-index
50
citations
13,310
works
179
NIH funding
primary concept
email

Recent publications

Evolving roles of CD38 metabolism in solid tumour microenvironment.
2023cited by 22position: contributordoi
IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor
Nature Immunology 2021cited by 362position: middledoi
IL-2 regulates tumor-reactive CD8<sup>+</sup> T cell exhaustion by activating the aryl hydrocarbon receptor.
2021cited by 288position: contributordoi
The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression.
2021cited by 24position: contributordoi
Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin.
2021cited by 23position: contributordoi
Combinatorial screening of a panel of FDA-approved drugs identifies several candidates with anti-Ebola activities.
2020cited by 31position: contributordoi
Targeting the tumor microenvironment to overcome immune checkpoint blockade therapy resistance.
2020cited by 30position: contributordoi
Tissue-specific deconvolution of immune cell composition by integrating bulk and single-cell transcriptomes.
2020cited by 15position: contributordoi
Azithromycin Protects against Zika Virus Infection by Upregulating Virus-Induced Type I and III Interferon Responses
Antimicrobial Agents and Chemotherapy 2019cited by 112position: middledoi
Type-I-IFN-Stimulated Gene TRIM5γ Inhibits HBV Replication by Promoting HBx Degradation
Cell Reports 2019cited by 71position: middledoi
Azithromycin Protects against Zika virus Infection by Upregulating virus-induced Type I and III Interferon Responses.
2019cited by 68position: contributordoi
Type-I-IFN-Stimulated Gene TRIM5γ Inhibits HBV Replication by Promoting HBx Degradation.
2019cited by 64position: contributordoi
Inhibition of Influenza A Virus Replication by TRIM14 via Its Multifaceted Protein-Protein Interaction With NP.
2019cited by 57position: contributordoi
Concomitant type I IFN and M-CSF signaling reprograms monocyte differentiation and drives pro-tumoral arginase production.
2019cited by 20position: contributordoi
Noncanonical Role of FBXO6 in Regulating Antiviral Immunity.
2019cited by 16position: contributordoi
Tumor-Repopulating Cells Induce PD-1 Expression in CD8+ T Cells by Transferring Kynurenine and AhR Activation
Cancer Cell 2018cited by 519position: middledoi
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade
Cancer Discovery 2018cited by 466position: middledoi
STAT3/p53 pathway activation disrupts IFN-β–induced dormancy in tumor-repopulating cells
Journal of Clinical Investigation 2018cited by 103position: middledoi
Broad and diverse mechanisms used by deubiquitinase family members in regulating the type I interferon signaling pathway during antiviral responses
Science Advances 2018cited by 96position: middledoi
Identification of TRIM14 as a Type I IFN-Stimulated Gene Controlling Hepatitis B Virus Replication by Targeting HBx
Frontiers in Immunology 2018cited by 62position: middledoi
25-Hydroxycholesterol Protects Host against Zika Virus Infection and Its Associated Microcephaly in a Mouse Model
Immunity 2017cited by 355position: middledoi
Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice
EBioMedicine 2017cited by 173position: middledoi
Type I IFN augments IL-27-dependent TRIM25 expression to inhibit HBV replication
Cellular and Molecular Immunology 2017cited by 75position: middledoi
TRIM14 inhibits hepatitis C virus infection by SPRY domain-dependent targeted degradation of the viral NS5A protein
Scientific Reports 2016cited by 90position: lastdoi
The antioxidative potential of farrerol occurs via the activation of Nrf2 mediated HO-1 signaling in RAW 264.7 cells
Chemico-Biological Interactions 2015cited by 45position: middledoi
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Nature Communications 2014cited by 986position: lastdoi
Interferon-Inducible Cholesterol-25-Hydroxylase Inhibits Hepatitis C Virus Replication via Distinct Mechanisms
Scientific Reports 2014cited by 96position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Genhong Cheng · University of California, Los Angeles8 papers (2014–2019) · 5 papers (2019–2023)Fengchao Xu · Jilin University3 papers (2017–2019)Roghiyh Aliyari · University of California, Los Angeles3 papers (2014–2019)Feng Ma · Academy of Medical Sciences3 papers (2017–2019)Guangyun Tan · Jilin University3 papers (2017–2019)Cheng‐Feng Qin · Academy of Military Medical Sciences3 papers (2017–2019)Chunfeng Li · Xi'an Shiyou University3 papers (2016–2019)Xiaosong Wang · Nanjing Agricultural University3 papers (2015–2019)Hongxiao Song · Jilin University3 papers (2017–2019)Di Peng · Chinese Academy of Fishery Sciences2 papers (2017–2019)Natalie Quanquin · Miller Children's & Women's Hospital2 papers (2017–2019)Karin Nielsen‐Saines · Mercy Hospital for Women2 papers (2017–2019)Jae U. Jung · Cleveland Clinic2 papers (2017–2019)Qingfei Xiao · Jilin University2 papers (2017–2018) · 2 papers (2014–2019)Lishan Su · Electoral Commission2 papers (2014–2019)Feng Li · Changchun University of Science and Technology2 papers (2019–2019)Yaoxing Wu · Sun Yat-sen University2 papers (2016–2018)Yongzhi Chen · National University of Singapore2 papers (2014–2016)